12 Nov 2021 07:33
12 November 2021
Â
Â
Roquefort Investments plc
("Roquefort Investments" or the "Company")
Â
Update on Acquisition of Lyramid Limited
Â
Roquefort Investments (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the medical biotechnology sector, is pleased to announce that it has commenced marketing to potential investors to fund the acquisition and pre-clinical drug development programme of Lyramid Limited, details of which were announced on 29 September 2021. A copy of the presentation is available on the Company's website at https://www.roquefortinvest.com/presentations
Â
The Company looks forward to providing further updates in relation to the acquisition of Lyramid Limited as and when appropriate.
Â
The Company's shares remain suspended from trading on the Main Market of the London Stock Exchange pending the publication of a Prospectus setting out full details of the potential transaction.
Â
Â
Enquiries:
Â
Roquefort Investments plc | |
Stephen West (Chairman) | +44 (0)20 3290 9339 |
Optiva Securities Limited (Joint Broker) | |
Christian Dennis | +44 (0)20 3411 1881 |
Â
For further information, please visit www.roquefortinvest.com and @roquefortinvest on Twitter.
Â
LEI: ‎254900P4SISIWOR9RH34